IMPC - International Mouse Phenotyping Consortium

The International Mouse Phenotyping Consortium (IMPC), founded in 2011, is a global initiative dedicated to systematically cataloguing mammalian gene function. Operating within the Business Services sector, IMPC focuses on the comprehensive phenotyping of knockout mice to advance the understanding of gene functions and their implications in human diseases and genetic disorders. Their extensive data resources include over 138 million data points and 9,605 phenotyped knockout genes, serving as a critical hub for researchers worldwide. IMPC actively collaborates with numerous research institutions and initiatives to fill knowledge gaps in genetic research and provide accessible information on gene-disease relationships.

IMPC's operational scale is significant, with an employee range of 1,000-5,000 individuals contributing to its mission. The consortium provides essential services such as data generation, specialized training programs, and access to advanced analytical tools for genetic information. Researchers can learn more about the dedicated individuals driving these efforts by accessing Meet IMPC - International Mouse Phenotyping Consortium's team. Their work is crucial for generating complete genetic models and understanding variations that lead to disease.

With a reported revenue of $87.5M, IMPC operates in a competitive landscape populated by major genomics and biotechnology firms, including ILLUMINA, LGC Biosearch Technologies, and Oxford Nanopore Technologies. The consortium's primary objective is to provide a complete pipeline of information on mouse strains and their associated phenotypes, thereby accelerating research into complex human health conditions and enabling the development of targeted therapeutic strategies.